Matches in Wikidata for { <http://www.wikidata.org/entity/Q88454049> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q88454049 description "article scientifique publié en 2017" @default.
- Q88454049 description "artículu científicu espublizáu en setiembre de 2017" @default.
- Q88454049 description "scientific article published on 01 September 2017" @default.
- Q88454049 description "wetenschappelijk artikel" @default.
- Q88454049 description "наукова стаття, опублікована у вересні 2017" @default.
- Q88454049 name "Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma" @default.
- Q88454049 name "Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma" @default.
- Q88454049 type Item @default.
- Q88454049 label "Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma" @default.
- Q88454049 label "Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma" @default.
- Q88454049 prefLabel "Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma" @default.
- Q88454049 prefLabel "Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma" @default.
- Q88454049 P1433 Q88454049-31440116-B857-4B2C-8602-B727F843C1D1 @default.
- Q88454049 P1476 Q88454049-230A0E57-C693-4BB1-8E36-F854B4AAFC6B @default.
- Q88454049 P2093 Q88454049-3ADB7553-944F-4436-BBCE-C948A05DA5E0 @default.
- Q88454049 P2093 Q88454049-52C7EC80-3F93-4D75-BA4F-4346EC6EE52A @default.
- Q88454049 P2093 Q88454049-530D65A0-AD67-41EA-AA3A-ECF76BEF288E @default.
- Q88454049 P2093 Q88454049-63EB05DD-FEEA-4857-88AD-60EC78CE658A @default.
- Q88454049 P2093 Q88454049-8F4724EA-33CD-4C99-87D6-85DD1D0D080C @default.
- Q88454049 P2093 Q88454049-A6281E99-AD28-42C7-9C02-1BC2C3595256 @default.
- Q88454049 P2093 Q88454049-BD13643E-D739-4A02-9C8E-82B63B9E9E48 @default.
- Q88454049 P304 Q88454049-39A2F97E-F105-42DC-B4D0-EBEAD0416EDB @default.
- Q88454049 P31 Q88454049-CD6A9BA7-62F0-4C3E-AEE5-74F869412B18 @default.
- Q88454049 P356 Q88454049-B4CF80DC-CC0C-4EF7-A2BF-2F40C675324E @default.
- Q88454049 P433 Q88454049-7DF09CE0-0E6E-40E7-AFB8-9C1565F05313 @default.
- Q88454049 P478 Q88454049-9D59BCAB-45F8-4277-92D2-7368E761678C @default.
- Q88454049 P577 Q88454049-01698449-7E76-4415-A06C-1A2EAAABD183 @default.
- Q88454049 P698 Q88454049-D19846C7-29D2-4D86-8E6B-932D09454A94 @default.
- Q88454049 P921 Q88454049-041BDAAC-7E32-4803-ACF2-0F1BC92CB65D @default.
- Q88454049 P921 Q88454049-4165BB37-80F3-47AC-9775-2010D4F95528 @default.
- Q88454049 P356 JAMADERMATOL.2017.1679 @default.
- Q88454049 P698 28678991 @default.
- Q88454049 P1433 Q3918707 @default.
- Q88454049 P1476 "Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma" @default.
- Q88454049 P2093 "Akifumi Yamamoto" @default.
- Q88454049 P2093 "Jun-Ichi Adachi" @default.
- Q88454049 P2093 "Ryo Nishikawa" @default.
- Q88454049 P2093 "Taisuke Matsuya" @default.
- Q88454049 P2093 "Yasuhiro Nakamura" @default.
- Q88454049 P2093 "Yukiko Teramoto" @default.
- Q88454049 P2093 "Yuri Asami" @default.
- Q88454049 P304 "942-944" @default.
- Q88454049 P31 Q13442814 @default.
- Q88454049 P356 "10.1001/JAMADERMATOL.2017.1679" @default.
- Q88454049 P433 "9" @default.
- Q88454049 P478 "153" @default.
- Q88454049 P577 "2017-09-01T00:00:00Z" @default.
- Q88454049 P698 "28678991" @default.
- Q88454049 P921 Q180152 @default.
- Q88454049 P921 Q18975855 @default.